Reig M, Forner A, Rimola J et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76:681–693
Bruix J, Gores GJ, Mazzaferro V (2014) Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63:844–855
Vitale A, Burra P, Frigo AC et al (2015) Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol 62:617–624
Wang Q, Xia D, Bai W et al (2019) Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study. J Hepatol 70:893–903
Centonze L, Di Sandro S, Lauterio A et al (2021) Surgical resection vs. percutaneous ablation for single hepatocellular carcinoma: exploring the impact of Li-RADS classification on oncological outcomes. Cancers 13:1671
Chu HH, Kim JH, Kim PN et al (2019) Surgical resection versus radiofrequency ablation very early-stage HCC (≤ 2 cm single HCC): a propensity score analysis. Liver Int 39:2397–2407
Trevisani F, Golfieri R (2016) Lipiodol transarterial chemoembolization for hepatocellular carcinoma: where are we now? Hepatology 64:23–25
Terzi E, Piscaglia F, Forlani L et al (2014) TACE performed in patients with a single nodule of hepatocellular carcinoma. BMC Cancer 14:601
Kudo M, Han KH, Ye SL et al (2020) A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements. Liver Cancer 9:245–260
Kim BK, Kim SU, Kim KA et al (2015) Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol 62:1304–1310
Irie T, Kuramochi M, Takahashi N (2011) Improved accumulation of lipiodol under balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma: measurement of blood pressure at the embolized artery before and after balloon inflation. Jpn J Intervent Radiol 26:49–54
Irie T, Kuramochi M, Takahashi N (2013) Dense accumulation of Lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 36:706–713
Arai H, Abe T, Takayama H et al (2015) Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatol Res 45:663–666
Irie T, Kuramochi M, Kamoshida T, Takahashi N (2016) Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatol Res 46:209–214
Golfieri R, Bezzi M, Verset G et al (2021) Balloon-occluded transarterial chemoembolization: In which size range does it perform best? A comparison of its efficacy versus conventional transarterial chemoembolization, using propensity score matching. Liver Cancer 10:522–534
Gaba RC, Lokken RP, Hickey RM et al (2017) Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy. J Vasc Interv Radiol 28:1210–1223
Kim PH, Gwon DI, Kim JW, Chu HH, Kim JH (2020) The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization. Eur Radiol 30:5650–5662
Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60
Park C, Gwon DI, Chu HH, Kim JW, Kim JH, Ko GY (2021) Correlation of tumor response on CT with pathologically proven necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral lipiodol accumulation predicting tumor necrosis. Abdom Radiol (NY) 46:3729–3737
Brown DB, Gould JE, Gervais DA et al (2009) Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S425–S434
Ju MJ, Tu GW, Han Y et al (2013) Effect of admission time on mortality in an intensive care unit in Mainland China: a propensity score matching analysis. Crit Care 17:R230
Golfieri R, Bezzi M, Verset G et al (2021) Retrospective European multicentric evaluation of selective transarterial chemoembolisation with and without balloon-occlusion in patients with hepatocellular carcinoma: a propensity score matched analysis. Cardiovasc Intervent Radiol 44:1048–1059
Lucatelli P, De Rubeis G, Rocco B et al (2021) Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study. BMC Gastroenterol 21:51
Cammà C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54
Kuroda C, Sakurai M, Monden M et al (1991) Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases. Cancer 67:81–86
Matsui O, Kadoya M, Yoshikawa J et al (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83
Takayasu K, Arii S, Matsuo N et al (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 175:699–704
Dioguardi Burgio M, Ronot M, Bruno O et al (2016) Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation. Liver Transpl 22:1491–1500
Kwan SW, Fidelman N, Ma E, Kerlan RK Jr, Yao FY (2012) Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl 18:727–736
Terayama N, Matsui O, Gabata T et al (2001) Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Intervent Radiol 24:383–387
Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608
Esnaola NF, Lauwers GY, Mirza NQ et al (2002) Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6:224–232
Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306
Golfieri R, Renzulli M, Mosconi C et al (2013) Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? J Vasc Interv Radiol 24:509–517
留言 (0)